Yonsei Med J.  2011 May;52(3):488-494. 10.3349/ymj.2011.52.3.488.

Association of beta2-Adrenergic Receptor Polymorphism with Work-Related Symptoms in Workers Exposed to Wheat Flour

Affiliations
  • 1Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • 2Department of Internal Medicine, Seobuk Hospital, Seoul, Korea.
  • 3Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea. hspark@ajou.ac.kr
  • 4Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency, Incheon, Korea.
  • 5Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

PURPOSE
Our previous study indicated that the presence of wheat-specific IgG1 and IgG4 antibodies was associated with work-related symptoms in workers exposed to wheat flour. We performed this study to investigate the genetic polymorphisms of beta2-adrenergic receptors and wheat-specific antibodies in association with the clinical parameters of baker's asthma.
MATERIALS AND METHODS
In total, 379 subjects working in a single industrial bakery were enrolled in this study. The skin prick test was performed with common inhalant allergens and wheat flour extract. The presence of serum- specific IgE, IgG1, and IgG4 antibodies to wheat flour were determined by ELISA. Whole blood samples were obtained for genotype analysis. Subjects were genotyped with regard to five candidate single nucleotide polymorphisms (SNPs) of the beta2-adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a single-base extension method.
RESULTS
No significant associations were observed between the genotype/allele frequencies of any of the SNPs tested and any clinical parameters. The haplotype of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly associated with work-related symptoms (p<0.05). Moreover, in subjects with the AG or GG genotype at 46 A>G and haplotype [GAA] of ADRB2, the prevalence rates of wheat-specific IgG1 antibodies and lower respiratory symptoms increased significantly with exposure intensity (both p<0.05).
CONCLUSION
The findings of the present study suggest that ADRB2 genetic polymorphism may contribute to the development of work-related symptoms in workers exposed to wheat flour, which can lead to baker's asthma.

Keyword

Baker's asthma; ADRB2 polymorphism; haplotype; specific IgG antibody

MeSH Terms

Adult
Allergens/*immunology
Asthma/genetics/*immunology
Enzyme-Linked Immunosorbent Assay
Female
*Flour
Haplotypes
Humans
Immunoglobulin G/immunology
Inhalation Exposure/analysis
Male
Occupational Exposure/analysis
*Polymorphism, Genetic
Polymorphism, Single Nucleotide
Receptors, Adrenergic, beta-2/*genetics
Skin Tests
Triticum/*immunology

Figure

  • Fig. 1 Predictive probabilities for the presence of serum-specific IgG antibodies to wheat flour in relation to exposure, according to the ADRB2 46A>G polymorphism.

  • Fig. 2 Predictive probabilities for the presence of serum-specific IgG antibodies to wheat flour in relation to exposure density, according to the genotype of ADRB2. *The haplotype was composed of 46A>G, 252G>A, and 523C>A of the β2-adrenergic receptor genetic polymorphism.


Reference

1. Baur X, Degens PO, Sander I. Baker's asthma: still among the most frequent occupational respiratory disorders. J Allergy Clin Immunol. 1998. 102:984–997.
Article
2. Meredith S. Reported incidence of occupational asthma in the United Kingdom, 1989-90. J Epidemiol Community Health. 1993. 47:459–463.
Article
3. Siracusa A, Kennedy SM, DyBuncio A, Lin FJ, Marabini A, Chan-Yeung M. Prevalence and predictors of asthma in working groups in British Columbia. Am J Ind Med. 1995. 28:411–423.
Article
4. Smith TA, Smith PW. Respiratory symptoms and sensitization in bread and cake bakers. Occup Med (Lond). 1998. 48:321–328.
Article
5. Houba R, Heederik D, Doekes G. Wheat sensitization and work-related symptoms in the baking industry are preventable. An epidemiologic study. Am J Respir Crit Care Med. 1998. 158:1499–1503.
Article
6. Cullinan P, Lowson D, Nieuwenhuijsen MJ, Gordon S, Tee RD, Venables KM, et al. Work related symptoms, sensitisation, and estimated exposure in workers not previously exposed to laboratory rats. Occup Environ Med. 1994. 51:589–592.
Article
7. Houba R, Van Run P, Heederik D, Doekes G. Wheat antigen exposure assessment for epidemiological studies in bakeries using personal dust sampling and inhibition ELISA. Clin Exp Allergy. 1996. 26:154–163.
Article
8. Baur X. Baker's asthma: causes and prevention. Int Arch Occup Environ Health. 1999. 72:292–296.
Article
9. Brisman J. Baker's asthma. Occup Environ Med. 2002. 59:498–502.
Article
10. Palosuo K. Update on wheat hypersensitivity. Curr Opin Allergy Clin Immunol. 2003. 3:205–209.
Article
11. Tiikkainen U, Klockars M. Clinical significance of IgG subclass antibodies to wheat flour antigens in bakers. Allergy. 1990. 45:497–504.
Article
12. Battais F, Pineau F, Popineau Y, Aparicio C, Kanny G, Guerin L, et al. Food allergy to wheat: identification of immunogloglin E and immunoglobulin G-binding proteins with sequential extracts and purified proteins from wheat flour. Clin Exp Allergy. 2003. 33:962–970.
Article
13. Pfeil T, Schwabl U, Ulmer WT, König W. Western blot analysis of water-soluble wheat flour (Triticum vulgaris) allergens. Int Arch Allergy Appl Immunol. 1990. 91:224–231.
Article
14. Hur GY, Koh DH, Kim HA, Park HJ, Ye YM, Kim KS, et al. Prevalence of work-related symptoms and serum-specific antibodies to wheat flour in exposed workers in the bakery industry. Respir Med. 2008. 102:548–555.
Article
15. Malo JL, Chan-Yeung M. Occupational asthma. J Allergy Clin Immunol. 2001. 108:317–328.
Article
16. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol. 1993. 8:334–339.
Article
17. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet. 2004. 364:1505–1512.
Article
18. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 1994. 33:9414–9419.
Article
19. Bahn JW, Lee JY, Jang SH, Kim SH, Kim HM, Park HS. Sensitization to Empynase(pronase B) in exposed hospital personnel and identification of the Empynase allergen. Clin Exp Allergy. 2006. 36:352–358.
Article
20. Mehl A, Verstege A, Staden U, Kulig M, Nocon M, Beyer K, et al. Utility of the ratio of food-specific IgE/total IgE in predicting symptomatic food allergy in children. Allergy. 2005. 60:1034–1039.
Article
21. Bernstein IL, Chan-Yeung M, Malo JL, Berstein D. Asthma in the workplace. 1999. 2nd ed. New York: Marcel Dekker Inc..
22. Di Stefano F, Siriruttanapruk S, McCoach J, Di Gioacchino M, Burge PS. Occupational asthma in a highly industrialized region of UK: report from a local surveillance scheme. Eur Ann Allergy Clin Immunol. 2004. 36:56–62.
23. McDonald JC, Keynes HL, Meredith SK. Reported incidence of occupational asthma in the United Kingdom, 1989-97. Occup Environ Med. 2000. 57:823–829.
Article
24. Liggett SB. The pharmacogenetics of beta2-adrenergic receptors: relevance to asthma. J Allergy Clin Immunol. 2000. 105:S487–S492.
25. D'amato M, Vitiani LR, Petrelli G, Ferrigno L, di Pietro A, Trezza R, et al. Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med. 1998. 158:1968–1973.
26. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med. 2000. 162:75–80.
Article
27. Cho SH, Oh SY, Bahn JW, Choi JY, Chang YS, Kim YK, et al. Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene. Clin Exp Allergy. 2005. 35:1162–1167.
Article
28. Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med. 2005. 171:563–570.
Article
29. Tsai HJ, Shaikh N, Kho JY, Battle N, Naqvi M, Navarro D, et al. Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Hum Genet. 2006. 119:547–557.
Article
30. Silverman EK, Kwiatkowski DJ, Sylvia JS, Lazarus R, Drazen JM, Lange C, et al. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. J Allergy Clin Immunol. 2003. 112:870–876.
Article
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr